ELAVL1 and pancreatic neoplasm: TSLNC8 interacted with HuR, facilitating HuR's binding to CTNNB1 mRNA and enhancing its stability, ultimately activating the WNT/β-catenin signaling pathway and promoting aggressiveness in pancreatic cancer cells.